Riociguat (Adempas, BAY 63-2521)

Phase 1Completed

0 views this week 0 watching💤 Quiet

Interest: 26/100

Hype Score

Development Stage

✓

Pre-clinical

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Clinical Pharmacology

Conditions

Clinical Pharmacology

Trial Timeline

Apr 14, 2010 → Sep 15, 2011

NCT ID

NCT04366622

About Riociguat (Adempas, BAY 63-2521)

Riociguat (Adempas, BAY 63-2521) is a phase 1 stage product being developed by Bayer for Clinical Pharmacology. The current trial status is completed. This product is registered under clinical trial identifier NCT04366622. Target conditions include Clinical Pharmacology.

What happened to similar drugs?

1 of 4 similar drugs in Clinical Pharmacology were approved

Approved (1) Terminated (1) Active (3)

🔄Lecanemab + PlaceboEisaiPhase 3

✅PosaconazoleMerckApproved

🔄Rebif®MerckPhase 3

🔄Cannabidiol (CBD) + PlaceboJazz PharmaceuticalsPhase 3

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (2)

NCT ID	Phase	Status	Start	Completion	Indication
NCT04366622	Phase 1	Completed	Apr 14, 2010	Sep 15, 2011	Clinical Pharmacology
NCT04364464	Phase 1	Completed	Feb 19, 2010	Sep 20, 2011	Clinical Pharmacology

Competing Products

20 competing products in Clinical Pharmacology

See all competitors

Product	Company	Stage	Hype Score
Lecanemab + Placebo	Eisai	Phase 3	44
Cetuximab + Cisplatin	Eli Lilly	Phase 2	27
Durvalumab + Tremelimumab	AstraZeneca	Phase 1/2	24
Posaconazole	Merck	Approved	35
Rebif®	Merck	Phase 3	40
Blinatumomab + olverembatinib	Amgen	Phase 2	42
Binimetinib + Nivolumab	Bristol Myers Squibb	Phase 2	27
Fluconazole (BAYT006267) 150 mg capsules + Fluconazole 150 mg capsules (DiflucanTM)	Bayer	Phase 1	26
Finerenone (BAY 94-8862) PEG solution + Finerenone (BAY 94-8862) immediate release tablet + Eplerenone (Inspra®) + Placebo	Bayer	Phase 1	26
Rivaroxaban (BAY 59-7939, Xarelto) in ODT form + Rivaroxaban (BAY 59-7939, Xarelto) in film-coated form	Bayer	Phase 1	26
Naproxen sodium and diphenhydramine hydrochloride soft capsules + Naproxen sodium and diphenhydramine hydrochloride coated tablets (Aleve PM, BAY98-7111)	Bayer	Phase 1	26
Fulacimstat (BAY1142524)	Bayer	Phase 1	26
Vilaprisan (BAY 1002670) + Vilaprisan Placebo + Microgynon + Microgynon Placebo	Bayer	Phase 1	26
Nifedipine gastrointestinal therapeutic system (GITS) (Adalat LA, BAY a1040) + Candesartan cilexetil	Bayer	Phase 1	26
BAY1817080 + Placebo + Itraconazole	Bayer	Phase 1	26
BAY1902607 + Placebo	Bayer	Phase 1	26
Fosrenol ODT (Lanthanum Carbonate, BAY77-1931) + Fosrenol chewable Tablet (Lanthanum Carbonate, BAY77-1931)	Bayer	Phase 1	26
Riociguat (Adempas, BAY63-2521) immediate release tablet of 2.5 mg + Placebo	Bayer	Phase 1	26
Neladenoson bialanate (BAY 1067197)	Bayer	Phase 1	18
Riociguat (Adempas, BAY 63-2521)	Bayer	Phase 1	26